-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PrEP-001 in Rhinovirus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PrEP-001 in Rhinovirus Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PrEP-001 in Rhinovirus Infections Drug Details: PrEP-001 (JNJ-43260295) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Drug To Inhibit Prolylendopeptidase (PREP) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Drug To Inhibit Prolylendopeptidase (PREP) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical...
-
Sector Analysis
NewUnited Kingdom (UK) Home Kitchen Storage Market Trends, Analysis, Consumer Dynamics and Spending Habits
The UK: Home Category Data, The Consumer - Kitchen Storage 2024 report offers a comprehensive insight into consumer attitudes in the UK kitchen storage market. The report focuses on four key subcategories: food storage, cleaning storage, storage racks, utensil storage. Consumer data is based on our 2024 UK kitchen storage survey, using a panel of 2,000 nationally representative consumers.
-
Product Insights
NewMiCo BioMed Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our MiCo BioMed Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. MiCo BioMed Co Ltd (Mico Biomed), formerly Nanobiosys Inc, is engaged in the research and development of bio-diagnostic chips, bio-reagents, and portable mini high speed diagnostic equipment based on Lab-on-a-Chip technology. The company offers molecular, biochemical and immunodiagnosis solutions. Its products include nucleic acid extraction equipment (prep equipment), gene amplification apparatus (realtime PCR), labchip, reagents, complex diagnostic (cholesterol),...
-
Product Insights
NewQuantuMDx Group Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our QuantuMDx Group Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. QuantuMDx Group Ltd (QuantuMDx) operates as a developer of sciences tools and diagnostics products. The company’s products include Q-POC, a handheld DNA analyzer that provides an accurate molecular diagnostic results. It develops assays for diagnosis and drug susceptibility testing of infectious diseases, and companion diagnostics assays and tumour profiling. QuantuMDx also develops technologies such as Q-PREP, Q-AMP, Q-DETECT, and...
-
Product Insights
NewMolbio Diagnostics Pvt Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Molbio Diagnostics Pvt Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Molbio Diagnostics Pvt Ltd (Molbio) is a medical device company that provides molecular diagnostic tools for accurate disease diagnostics. The company’s products include real time micro PCR workstation, chip-based real time PCR tests, and auto sample prep kits and accessories. Its real time quantitative micro PCR system comprise all the equipments, reagents and accessories for conducting rapid, microchip...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Triple-Negative Breast Cancer (TNBC) Drug Details: Leronlimab (PRO-140)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leronlimab in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: Leronlimab (PRO-140)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Drug To Inhibit Prolylendopeptidase (Prep) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Drug To Inhibit Prolylendopeptidase (Prep) For Chronic Obstructive Pulmonary Disease in Chronic Obstructive Pulmonary Disease (COPD)...